Browsing

2012

Symic Bio, Inc.

Symic Bio is a biopharmaceutical company developing a new category of therapeutics focused on matrix biology. The (extracellular) matrix is the non-cellular component of the body’s…

Tolerion, Inc.

Tolerion is a clinical-stage biopharmaceutical company using our proprietary therapeutic platform to develop a pipeline of novel products to treat autoimmune diseases in a…

Opthea Limited

Opthea is committed to improving vision in patients suffering from retinal eye diseases. Opthea develops a novel therapeutic called OPT-302, a VEGF-C/D ‘trap’, to be used in…

Ovensa Inc.

Ovensa is a preclinical stage company working to fight inherent therapeutic resistance in complex diseases by generating advanced nanotherapeutics through its proprietary TRIOZAN…

Nanna Therapeutics Ltd.

Nanna Therapeutics is a 21st century drug discovery company addressing age-related diseases for which others are failing to provide effective treatments. These include…

NHTherapeutics

NHTherapeutics (NHT) stands for Neurohormone Therapeutics and is a clinical stage pharmaceutical company that aims to normalize hormonal levels in patients suffering from…

For-Robin, Inc.

For-Robin, Inc, founded in 2012 is an antibody immunotherapy company whose primary mission is developing treatments for breast and lung cancer patients. For-Robin's proprietary…

AdvanceCOR GmbH

AdvanceCor GmbH, a drug development company, researches, develops, and commercializes therapeutics and diagnostics for the personalized treatment of heart and vascular diseases. It…

Alfacyte Ltd.

Alfacyte is generating a pipeline of therapeutic drug candidates leveraging its 'bio-brick' development platform. Alfacyte's aim is to develop innovative alpha-interferon…

Ayana Pharma LTD

Ayana Pharma develops liposome-based treatments for cancer. Ayana was formed to leverage the benefits of the anticancer drug Doxil.